EXPRESSION LEVEL OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 IN RADICAL NEPHRECTOMY SPECIMENS AS A PROGNOSTIC PREDICTOR IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUNITINIB

被引：0
|
作者：
Terakawa, Tomoaki
Miyake, Hideaki
Kusuda, Yuji
Fujisawa, Masato
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.1819
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1788
引用
收藏
页码：E721 / E722
页数：2
相关论文
共 50 条
  • [21] Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Expression in the Chick Embryo Area Vasculosa
    Beatrice Nico
    Angelo Vacca
    Michela De Giorgis
    Luisa Roncali
    Domenico Ribatti
    The Histochemical Journal, 2001, 33 : 283 - 286
  • [22] Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 expression in the chick embryo area vasculosa
    Nico, B
    Vacca, A
    De Giorgis, M
    Roncali, L
    Ribatti, D
    HISTOCHEMICAL JOURNAL, 2001, 33 (05): : 283 - 286
  • [23] Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
    Motzer, R. J.
    Escudier, B.
    Bukowski, R.
    Rini, B. I.
    Hutson, T. E.
    Barrios, C. H.
    Lin, X.
    Fly, K.
    Matczak, E.
    Gore, M. E.
    BRITISH JOURNAL OF CANCER, 2013, 108 (12) : 2470 - 2477
  • [24] Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
    R J Motzer
    B Escudier
    R Bukowski
    B I Rini
    T E Hutson
    C H Barrios
    X Lin
    K Fly
    E Matczak
    M E Gore
    British Journal of Cancer, 2013, 108 : 2470 - 2477
  • [25] Prognostic tissue biomarker exploration for patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor tyrosine kinase inhibitors
    Park, Inkeun
    Cho, Yong Mee
    Lee, Jae-Lyun
    Ahn, Jin-Hee
    Lee, Dae-Ho
    TUMOR BIOLOGY, 2016, 37 (04) : 4919 - 4927
  • [26] EXPRESSION LEVELS OF PD-L1 AND PD-L2 EXPRESSION IN RADICAL NEPHRECTOMY SPECIMENS AS PROGNOSTIC PREDICTORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH TYROSINE KINASE INHIBITORS
    Hara, Takuto
    Miyake, Hideaki
    Fujisawa, Masato
    JOURNAL OF UROLOGY, 2016, 195 (04): : E124 - E124
  • [27] Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Therapy
    Golshayan, Ali Reza
    George, Saby
    Heng, Daniel Y.
    Elson, Paul
    Wood, Laura S.
    Mekhail, Tarek M.
    Garcia, Jorge A.
    Aydin, Hakan
    Zhou, Ming
    Bukowski, Ronald M.
    Rini, Brian I.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) : 235 - 241
  • [28] NLR as prognostic biomarker for metastatic renal cell carcinoma patients treated with cytoreductive nephrectomy
    Liu, Huanrui
    Li, Senlin
    Zhang, Fan
    He, Weiyang
    Gou, Xin
    Zhang, Xu
    Xie, Yongpeng
    BIOMARKERS IN MEDICINE, 2025,
  • [29] NLR as prognostic biomarker for metastatic renal cell carcinoma patients treated with cytoreductive nephrectomy
    Liu, Huanrui
    Li, Senlin
    Zhang, Fan
    He, Weiyang
    Gou, Xin
    Zhang, Xu
    Xie, Yongpeng
    BIOMARKERS IN MEDICINE, 2025, 19 (06) : 215 - 222
  • [30] Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy
    Hall, Peter E.
    Shepherd, Scott T. C.
    Brown, Janet
    Larkin, James
    Jones, Robert
    Ralph, Christy
    Hawkins, Robert
    Chowdhury, Simon
    Boleti, Ekaterini
    Bahl, Amit
    Fife, Kate
    Webb, Andrew
    Crabb, Simon J.
    Geldart, Thomas
    Hill, Robert
    Dunlop, Joanna
    McLaren, Duncan
    Ackerman, Charlotte
    Wimalasingham, Akhila
    Beltran, Luis
    Nathan, Paul
    Powles, Thomas
    EUROPEAN UROLOGY FOCUS, 2020, 6 (05): : 999 - 1005
12345